C4 Therapeutics, Inc.

CCCC · Healthcare

$3.87

Markedsværdi: 476.11M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe C4 Therapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire4. sep. 2026, 12.30

Nearly 7 in 10 Canadian employees surveyed expect trade with China to increase over the next two years, reveals CCCC 2026 survey

GlobeNewswire3. sep. 2026, 11.00

C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting